Foundation Fighting Blindness Retinal Degeneration Fund
Director
SaleAlert
- Shares
- 556,000
- Price
- $4.96
- Value
- $2,755,981
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•53 filings
IRD
Opus Genetics, Inc.
Net sales of $2.8M over the last 3 months
2 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$2,755,981
0 buyers · 2 sellers
12-month purchases
$323,693
1 distinct insiders
12-month sales
$18,750,981
2 distinct insiders
Highlighted alerts
5
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get IRD insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
IRD overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
58
Raw transactions
Everything returned by the filing
5
Voluntary view
P/S trades after deterministic checks
53
Administrative noise
Stored, never alerted
2
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 4,767
- Price
- $3.57
- Footnotes
- 1
The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Issuer to satisfy tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units. This transaction does not represent a discretionary trade by the Reporting Person.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Foundation Fighting Blindness Retinal Degeneration Fund
Director
SaleAlert
- Shares
- 1,700,000
- Price
- $4.35
- Value
- $7,395,000
Gallagher Cam
Director
PurchaseAlert
- Shares
- 83,000
- Price
- $1.97
- Value
- $163,419
Gallagher Cam
Director
PurchaseAlert
- Shares
- 81,000
- Price
- $1.98
- Value
- $160,275
Foundation Fighting Blindness Retinal Degeneration Fund
Director
SaleAlert
- Shares
- 4,000,000
- Price
- $2.15
- Value
- $8,600,000
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund Director | Sale | 556,000 | $4.96 | $2,755,981 | |
| May 18, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund Director | Sale | 1,700,000 | $4.35 | $7,395,000 | |
| Dec 29, 2025 | Gallagher Cam Director | Purchase | 83,000 | $1.97 | $163,419 | |
| Dec 29, 2025 | Gallagher Cam Director | Purchase | 81,000 | $1.98 | $160,275 | |
| Dec 09, 2025 | Foundation Fighting Blindness Retinal Degeneration Fund Director | Sale | 4,000,000 | $2.15 | $8,600,000 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.